• Best Practices New Normal
  • Digital Dentistry
  • Data Security
  • Implants
  • Catapult Education
  • COVID-19
  • Digital Imaging
  • Laser Dentistry
  • Restorative Dentistry
  • Cosmetic Dentistry
  • Periodontics
  • Oral Care
  • Evaluating Dental Materials
  • Cement and Adhesives
  • Equipment & Supplies
  • Ergonomics
  • Products
  • Dentures
  • Infection Control
  • Orthodontics
  • Technology
  • Techniques
  • Materials
  • Emerging Research
  • Pediatric Dentistry
  • Endodontics
  • Oral-Systemic Health

Innovator Profile 2015: Dental Arts Laboratories, Inc.

Article

Dental Arts Laboratories, Inc., is excited to announce the arrival of the next evolution in dentistry … cubeX² cubic zirconia.

Dental Arts Laboratories, Inc., is excited to announce the arrival of the next evolution in dentistry … cubeX² cubic zirconia.

The cubic/tetragonal microstructure, which is previously unknown with current zirconium oxides and to which the material owes its characterization as cubic zirconia, is basically responsible for its extremely high translucency and strength.

Most all ceramic restorative materials experience a degradation of strength values over time in vivo due to aging/phase transformation. Due to the enhanced stability of the cubic phase in cubeX2 (versus the tetragonal phase found in conventional zirconia products), less phase transformation is observed in vivo, allowing cubeX2 to retain much more of its initial strength over time.

Convenience of conservative preparation and cementation
cubeX² requires less tooth preparation than lithium disilicate. Ideally, an .8 mm chamfer or rounded shoulder prep is preferred; however, a feather-edge margin is acceptable. The required occlusal reduction is between 1.0 mm and 1.5 mm.

Conventional resin-modified glass ionomer cements are recommended when adequate retention is present (4 mm or longer) or resin cements for short or tapered preparations.

Related reading: cubex2 zirconia: The next evolution of zirconia

Designed specifically for today’s dentistry
Both dentists and patients love the translucency and the warm, chameleon effect that cubeX² exhibits intraorally.

“In my practice, monolithic zirconia is here to stay. However, due to its lack of translucency, it has been primarily indicated for posterior applications,” says Dr. Leonard Hess, senior instructor of the Dawson Academy. “Finally, the wait for a zirconia product that has both superior esthetics and strength is now available. cubeX² cubic zirconia is my new first choice for a monolithic material in all tooth positions.”

The combination of durability along with the enhanced translucency and the resultant exceptional lifelike esthetics of cubeX² make it the restoration of choice for both anterior and posterior applications.

In brief
The new cubeX² cubic molecular structure (720 MPas) creates a new category of zirconia that features maximum translucency with outstanding stability and strength.

cubeX² is precision milled in just five working days at a flat rate cost of $109/unit. You no longer need to choose between lithium disilicate and conventional zirconia when cubeX² provides both beauty and strength.

Related reading: New cubic zironia material approved by the FDA

Related Videos
2024 Dental Products Report Spring Selection Bracket Reveal Video
Process of Care Workflow and Repairing Early Caries with Guided Enamel Remineralization
Addressing Unmet Needs in Early Childhood Oral Care - an interview with Ashlet Lerman, DDS
Mastermind Episode 33 – Charting the Course for the Future of Dentistry
CDS 2024 Midwinter Meeting – Interview with Debbie Zafiropoulos, who discusses a trio of new infection control products from Armis Biopharma.
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
CDS 2024: Ivoclar's e.max ZirCAD Prime Blocks with Shashi Singhal, BDS, MS
CDS 2024: Diving Deep on J. Morita's New Root ZX3 & HF Module
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
Related Content
© 2024 MJH Life Sciences

All rights reserved.